Seeking Alpha

Valeant (VRX) announces management appointments that will take place once the company closes its...

Valeant (VRX) announces management appointments that will take place once the company closes its acquisition of Medicis (MRX), which it expects on Dec 11. Ray Weldon, who's been at Valeant since 2008, will lead its U.S. Dermatology operations while Medicis COO Jason Hanson will lead certain U.S and international businesses and functions.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs